DK123823B - Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider. - Google Patents

Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider.

Info

Publication number
DK123823B
DK123823B DK495969AA DK495969A DK123823B DK 123823 B DK123823 B DK 123823B DK 495969A A DK495969A A DK 495969AA DK 495969 A DK495969 A DK 495969A DK 123823 B DK123823 B DK 123823B
Authority
DK
Denmark
Prior art keywords
thiopyrimidine
thio
preparation
azapyrimidine
nucleosides
Prior art date
Application number
DK495969AA
Other languages
English (en)
Inventor
P Strehlke
H Vorbrueggen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK123823B publication Critical patent/DK123823B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0898Compounds with a Si-S linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12Triazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK495969AA 1968-09-18 1969-09-17 Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider. DK123823B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681795357 DE1795357A1 (de) 1968-09-18 1968-09-18 2-Thio-pyrimidin-nucleoside

Publications (1)

Publication Number Publication Date
DK123823B true DK123823B (da) 1972-08-07

Family

ID=5708152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK495969AA DK123823B (da) 1968-09-18 1969-09-17 Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider.

Country Status (18)

Country Link
US (1) US3708469A (da)
JP (1) JPS5250795B1 (da)
AT (1) AT311560B (da)
BE (1) BE739035A (da)
BR (1) BR6912517D0 (da)
CA (1) CA930732A (da)
CH (1) CH523893A (da)
DE (1) DE1795357A1 (da)
DK (1) DK123823B (da)
ES (1) ES371463A1 (da)
FR (1) FR2018355B1 (da)
GB (1) GB1286854A (da)
IE (1) IE33314B1 (da)
NL (1) NL6914196A (da)
PH (1) PH9966A (da)
PL (1) PL80196B1 (da)
RO (1) RO54466A (da)
SE (1) SE364513B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH541566A (de) * 1969-04-11 1973-09-15 Schering Ag Verfahren zur Herstellung von Nucleosiden
DE2032424A1 (de) * 1970-06-23 1972-01-20 Schering AG, Berlin und Bergkamen, 1000 Berlin 2 Thio 5 aza cytosin und dessen Nucleoside
FR2066931A2 (en) * 1970-10-30 1971-08-13 Schering Ag 2-thio -6-aza-uridine derivs
US3975374A (en) * 1970-12-21 1976-08-17 The Upjohn Company Process for preparing 2-thiouracil nucleosides
GB1376437A (en) * 1970-12-21 1974-12-04 Upjohn Co Nucleoside derivatives and the preparation thereof
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden
US4090021A (en) * 1971-10-08 1978-05-16 Schering Aktiengesellschaft Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
US3919193A (en) * 1973-07-06 1975-11-11 Icn Pharmaceuticals 3-Deazaguanosine and derivatives thereof
US4171431A (en) * 1976-08-19 1979-10-16 The Upjohn Company Nucleosides and process
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
US4423212A (en) * 1980-12-18 1983-12-27 The Upjohn Company Nucleosides and process
US4760137A (en) * 1984-08-06 1988-07-26 Brigham Young University Method for the production of 2'-deoxyadenosine compounds
CA1269659A (en) * 1984-08-06 1990-05-29 Brigham Young University Method for the production of 2'-deoxyadenosine compounds

Also Published As

Publication number Publication date
FR2018355A1 (da) 1970-05-29
CA930732A (en) 1973-07-24
SE364513B (da) 1974-02-25
US3708469A (en) 1973-01-02
ES371463A1 (es) 1971-10-16
NL6914196A (da) 1970-03-20
IE33314L (en) 1970-03-18
AT311560B (de) 1973-11-26
IE33314B1 (en) 1974-05-15
JPS5250795B1 (da) 1977-12-27
PH9966A (en) 1976-06-16
PL80196B1 (da) 1975-08-30
FR2018355B1 (da) 1974-02-22
CH523893A (de) 1972-06-15
GB1286854A (en) 1972-08-23
SU399133A3 (da) 1973-09-27
DE1795357A1 (de) 1972-01-05
RO54466A (da) 1973-05-17
BE739035A (da) 1970-03-18
BR6912517D0 (pt) 1973-05-10

Similar Documents

Publication Publication Date Title
DK127923B (da) Fremgangsmåde til fremstilling af maltitol.
DK126193B (da) Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin.
DK122964B (da) Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater.
DK123823B (da) Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider.
DK123715B (da) Fremgangsmåde til fremstilling af 4'-demethylepipodophyllotoxin-β-D-alkylidenglucosider.
DK137498B (da) Analogifremgangsmåde til fremstilling af triazolpyrimidinderivater.
DK119765B (da) Fremgangsmåde til fremstilling af digitoxigeninglycosider.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK129656B (da) Analogifremgangsmåde til fremstilling af derivater af S-triazin.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK119304B (da) Fremgangsmåde til fremstilling af D-ribose.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK131863B (da) Analogifremgangsmåde til fremstilling af thiazolino- eller thiazidino-pyrimidinderivater.
DK128540B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinonforbindelser.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK120292B (da) Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater.
DK122132B (da) Analogifremgangsmåde til fremstilling af [(fenylamino)-pyridyl-3]-5-tetrazoler.
DK140726B (da) Fremgangsmåde til fremstilling af delta2-cephalosporin-forbindelser.
DK123479B (da) Fremgangsmåde til fremstilling af chromanoler.
DK121084B (da) Fremgangsmåde til fremstilling af benzomorphanderivater.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK140284B (da) Analogifremgangsmåde til fremstilling af oxazinobenzodiazepiner.
DK127554B (da) Analogifremgangsmåde til fremstilling af 14α 17α-methylendioxy-19-nor-progesteronderivater.